首页>
外国专利>
New 2-imino-imidazolidine derivs. have alpha=2-adrenergic activity - and venotonic activity, and are useful in phlebological disorders and venous insufficiency
New 2-imino-imidazolidine derivs. have alpha=2-adrenergic activity - and venotonic activity, and are useful in phlebological disorders and venous insufficiency
2-iminoimidazolidine derivs. of formulae (I) and their salts with acids such as carboxylic, sulphonic or phosphoric acid are new where X = CO; and Y-Z=C=C(R1) or CH-CHR; or X-Y= C(R1)=C, C(Ar)=C or CH(Ar)-CH; and Z = CO; R = H or acetyl; R1 = H or CH3; R2, R3, R4, R5 = H, F, Cl, Br, CF3, OH, OCH3, or acyloxy (e.g. acetyl-, propionyl-, butyryl- or isobutyryl-oxy of carboxymethyloxy or 1 alpha- or 1 beta-D-glucopyranosyloxy); Ar = phenyl opt. substd. in position 3 or position 4 by OH, OCH3 or acyloxy (e.g. acetyl-, propionyl-, butyryl- or isobutyryl- oxy) or by OH in position 3 or 4 and by OCH3 or acyloxy(as above) in position 4 or 3. USE/ADVANTAGE - (I) have alpha-2-adrenergic and venotonic activity and hence are useful in phlebological disorders and venous insufficiency. Related 2-(arylimino)imidazolidine cpds. such as alonidine have antihypertensive properties acting centrally by passage through the blood-brain barrier. The claimed cpds. still have the alpha-2-adrenergic activity but replacement of the aromatic fragment with a coumarin, chromone or flavone structure gives reduced lipophilicity and improved venous activity without arterial effects.
展开▼
机译:2-亚氨基咪唑烷衍生物。式(I)的化合物及其与酸如羧酸,磺酸或磷酸的盐是新的,其中X = CO;并且Y-Z = C = C(R1)或CH-CHR;或X-Y = C(R1)= C,C(Ar)= C或CH(Ar)-CH; Z = CO; R = H或乙酰基; R1 = H或CH3; R 2,R 3,R 4,R 5 = H,F,Cl,Br,CF 3,OH,OCH 3或酰氧基(例如羧甲基氧基的乙酰氧基,丙酰基,丁酰基或异丁氧基或1个α-或1个β-D-吡喃葡糖氧基); Ar =苯基。取代在位置3或4处通过OH,OCH3或酰氧基(例如乙酰基,丙酰基,丁酰基或异丁酰氧基)或在位置3或4中的OH以及在位置4或3中的OCH3或酰氧基(如上所述)。用途/优点-(I)具有α-2-肾上腺素能和血管收缩活性,因此可用于静脉疾病和静脉功能不全。相关的2-(芳基氨基)咪唑烷cpds。如可乐定等具有降压作用,可通过血脑屏障而集中发挥作用。声称的cpds。仍然具有α-2-肾上腺素能活性,但是用香豆素,色酮或黄酮结构替代芳香族片段会降低亲脂性并改善静脉活性,而没有动脉效应。
展开▼